Funding focus is a new series analysing cash flow into the European tech ecosystem. After debuting with a look at the biggest rounds so far this year, we now turn to the largest deals in the Netherlands for H1.

Startups in the Netherlands raised just $503mn (€429mn) in the first quarter of this year — the lowest quarterly total since the early days of the COVID-19 pandemic, according to Dealroom data. But three months later, the outlook has improved.

Total funding for the first half of 2025 hit $1.4bn (€1.2bn). That’s down from $1.8bn (€1.54bn) at the same point last year, but up from $1.1bn (€940) in H1 2023.

The rebound was driven by a much stronger second quarter, during which startups secured $856mn (€940mn) — a 70% jump from Q1.

The 💜 of EU tech

The latest rumblings from the EU tech scene, a story from our wise ol’ founder Boris, and some questionable AI art. It’s free, every week, in your inbox. Sign up now!

Leading the momentum is biotech, with half of the top 10 funding rounds in H1 coming from startups with a grounding in the life sciences. Here’s the full list.

1.Azafaros — €132M 

HQ: Leiden 

Azafaros develops small-molecule drugs targeting rare metabolic disorders. The company raised €132mn in a Series B round in June 2025.

2. Finom — €115M

HQ: Amsterdam 

Finom operates a pan-European neobank for SMEs and entrepreneurs. It raised a €115mn Series C in June, following a €50mn Series B round the previous year.  

3. Mews — €64M

HQ: Amsterdam 

Hospitality platform Mews secured $75mn (€64mn) in March. In total, Mews has bagged over $500mn (€425mn) to date, making it one of the Netherlands’ best-funded scaleups.

4. Toloka — €62M

HQ: Amsterdam 

Toloka is a crowdsourcing platform that uses a global network of human workers to label and evaluate data — text, images, audio, and more — for training and improving AI models. The business is part of Dutch AI infrastructure company Nebius. 

In May, Toloka raised $72mn (€62mn) in a funding round led by Jeff Bezos’ investment firm, Bezos Expeditions.

5. Leyden Labs — €60M

HQ: Leiden

Leyden Labs is developing intranasal medicines to protect against respiratory viruses. In January, it raised $70mn (€60mn), bringing its total raised to $257mn (€220mn). 

6. Alesta Therapeutics — €56M

HQ: Leiden

Alesta Therapeutics is another biotech startup from Leiden — home to one of Europe’s leading life science hubs. The company focuses on developing small-molecule therapies for rare diseases, which are taken orally. In January, it raised $65mn (€56mn) in Series A funding.  

7. Salvia BioElectronics — €53M 

HQ: Eindhoven

Salvia BioElectronics makes soft brain implants to treat chronic migraines using gentle electrical pulses. In May, the startup raised €53mn in Series B funding.

8. Avidicure —  €44M

HQ: Amsterdam

Avidicure develops antibody therapies to activate the immune system and treat cancer. In April, it raised a hefty €44mn seed round to accelerate R&D.   

9. Piano — €38M

HQ: Amsterdam

Piano offers tools that help businesses understand their customers’ online behaviour and deliver personalised content or offers to keep them engaged and increase sales. In February, it raised $45mn (€38mn) in Series D funding. 

10. Vivici — €32.5M

Vivici is a foodtech startup using precision fermentation to produce animal-free dairy proteins. Its proteins are designed to replace traditional dairy ingredients like whey and casein. In February, it raised €32.5m in Series A funding.



Source link